237 related articles for article (PubMed ID: 28740547)
21.
Chen P; He YH; Huang X; Tao SQ; Wang XN; Yan H; Ding KS; Lobie PE; Wu WY; Wu ZS
Oncotarget; 2017 Oct; 8(46):80709-80721. PubMed ID: 29113338
[TBL] [Abstract][Full Text] [Related]
22. A double feedback loop mediated by microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression.
Ma S; Liu M; Xu Z; Li Y; Guo H; Ge Y; Liu Y; Zheng D; Shi J
Oncotarget; 2016 Mar; 7(12):13502-19. PubMed ID: 26540574
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival.
Sánchez-Sendra B; Martinez-Ciarpaglini C; González-Muñoz JF; Murgui A; Terrádez L; Monteagudo C
Sci Rep; 2018 Nov; 8(1):17076. PubMed ID: 30459436
[TBL] [Abstract][Full Text] [Related]
24. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
[TBL] [Abstract][Full Text] [Related]
25. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
Biomed Pharmacother; 2019 Feb; 110():656-666. PubMed ID: 30551118
[TBL] [Abstract][Full Text] [Related]
26. Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.
Long J; Menggen Q; Wuren Q; Shi Q; Pi X
Med Sci Monit; 2018 Mar; 24():1547-1559. PubMed ID: 29543785
[TBL] [Abstract][Full Text] [Related]
27. miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma.
Rang Z; Yang G; Wang YW; Cui F
Biochem Biophys Res Commun; 2016 May; 474(2):315-320. PubMed ID: 27107696
[TBL] [Abstract][Full Text] [Related]
28. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X
Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241
[TBL] [Abstract][Full Text] [Related]
29. MiR-338-5p promotes metastasis of colorectal cancer by inhibition of phosphatidylinositol 3-kinase, catalytic subunit type 3-mediated autophagy pathway.
Chu CA; Lee CT; Lee JC; Wang YW; Huang CT; Lan SH; Lin PC; Lin BW; Tian YF; Liu HS; Chow NH
EBioMedicine; 2019 May; 43():270-281. PubMed ID: 30982765
[TBL] [Abstract][Full Text] [Related]
30. miR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer.
Zheng H; Li W; Wang Y; Xie T; Cai Y; Wang Z; Jiang B
Carcinogenesis; 2014 Jan; 35(1):173-83. PubMed ID: 23929433
[TBL] [Abstract][Full Text] [Related]
31. Identification and Functional Evaluation of miR-4633-5p as a Biomarker and Tumor Suppressor in Metastatic Melanoma.
Zou B; Zhu W; Liu H; Wang S; Zhu H
Cell Physiol Biochem; 2018; 49(4):1364-1379. PubMed ID: 30205394
[TBL] [Abstract][Full Text] [Related]
32. Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinoma.
Komatsu S; Ichikawa D; Kawaguchi T; Takeshita H; Miyamae M; Ohashi T; Okajima W; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Otsuji E
Oncotarget; 2016 Sep; 7(38):62034-62048. PubMed ID: 27566562
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.
Chang RM; Yang H; Fang F; Xu JF; Yang LY
Hepatology; 2014 Oct; 60(4):1251-63. PubMed ID: 24825302
[TBL] [Abstract][Full Text] [Related]
34. MiR-23a functions as a tumor suppressor in osteosarcoma.
He Y; Meng C; Shao Z; Wang H; Yang S
Cell Physiol Biochem; 2014; 34(5):1485-96. PubMed ID: 25322765
[TBL] [Abstract][Full Text] [Related]
35. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
36. Anti-miRNA-23a oligonucleotide suppresses glioma cells growth by targeting apoptotic protease activating factor-1.
Lian S; Shi R; Bai T; Liu Y; Miao W; Wang H; Liu X; Fan Y
Curr Pharm Des; 2013; 19(35):6382-9. PubMed ID: 23865473
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-23a promotes colorectal cancer cell survival by targeting PDK4.
Deng YH; Deng ZH; Hao H; Wu XL; Gao H; Tang SH; Tang H
Exp Cell Res; 2018 Dec; 373(1-2):171-179. PubMed ID: 30342991
[TBL] [Abstract][Full Text] [Related]
38. MiR-23a promotes TGF-β1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/β-catenin signaling.
Ma F; Li W; Liu C; Li W; Yu H; Lei B; Ren Y; Li Z; Pang D; Qian C
Oncotarget; 2017 Sep; 8(41):69538-69550. PubMed ID: 29050223
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
40. MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82.
Long J; Luo J; Yin X
Biomed Pharmacother; 2018 Jun; 102():1195-1202. PubMed ID: 29710538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
